Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Germany

 

Second wave of state financial support for private hospitals

Governments across Western Europe are re-instating financial support for private hospitals involved in the second wave pandemic response. Some are treating COVID patients for the first time as hospitalisations soar above first wave numbers, but support packages are heavily-adjusted from those in spring. We talk to operators in Italy, Portugal, Germany and Switzerland and provide an update on the UK and France.
November 19, 2020

Diaverum to IPO in Stockholm as Saudi JV buyout boosts EBITA

Global renal care group Diaverum's upcoming Stockholm IPO has 'strong international and Swedish investor interest', CEO Dimitris Moulavasilis tells HBI, as the market reaches historic highs. We talk expansion and diversification plans and 2020 performance. 
November 18, 2020

Lifting the lid on West Europe’s €60bn private non-profit hospitals

What does the non-profit hospital sector look like in West Europe and elsewhere? We are about to publish a special HBI Intelligence report, detailing market size and consolidation in eight countries, growth, potential privatisations and the expansion of US Academic Medical Centres abroad.
November 12, 2020

Artemis “enters sales process”

Artemis, Germany's second largest ophthalmology chain by revenue, has entered a sales process, HBI hears from multiple sources.
November 5, 2020

Propco M&A sees flurry of activity

October was the second most active month for healthcare property investments to date this year, with three of Europe's largest specialist healthcare propcos, plus a fourth player, making six deals for a total of around €300-350m.
November 5, 2020

Europe’s largest specialist leukaemia lab on sale for €480m

Munich Leukaemia Laboratory (MLL), a specialist founder-owned lab in Germany, is for sale with a potential €480m price tag. A source says it's one of the "most modern genetics labs" in the world and is likely to sell to one of the large lab groups.
November 5, 2020

Asklepios: €730m loan ‘nothing to do with’ COVID in Q4, as occupancies fall

Germany for-profit hospital group Asklepios's €730m Schuldschein, a debt instrument raised last week, has nothing to do with the potential negative financial impact of COVID-19 in Q4, CFO Hafid Rifi tells HBI, though he adds that occupancy in the hospital sector is falling. 95% of the amount will be used to refinance the Rhoen acquisition financing. 
November 5, 2020

Private equity targeting €1.2bn Mediq

Netherlands-based medicalised homecare provider and pharmaceutical distributor Mediq is for sale, with a potential €1.2bn price tag. With non-binding bids for the pan-European group due in the first week of November, HBI hears that a private equity buyer is almost certain with little interest from strategic parties.
October 29, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us